HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry.

Abstract
The synthesis and screening of two beta-D-Galp-(1-3)-beta-d-GlcpN (lacto-N-biose) disaccharide libraries are reported. Solution-phase synthetic modifications at the HO-2' and NH positions were performed in an effort to enhance the affinity toward galectin-3, a galactose-binding protein involved in tumor metastasis, apoptosis, and inflammation. The libraries were screened for galectin-3 binding by microscale frontal affinity chromatography coupled to mass spectrometry (FAC/MS) allowing for rapid ranking of the different inhibitors and the determination of the galectin-3 binding Kd's. Compounds bearing a hydrophobic substituent on the NH group showed the highest affinity for the lectin. The N-naphthoyl derivative (Kd = 10.6 microM) was the best inhibitor with a 7 times increased affinity as compared to the N-acetyl parent compound (Kd = 73.3 microM).
AuthorsSébastien Fort, Hyo-Sun Kim, Ole Hindsgaul
JournalThe Journal of organic chemistry (J Org Chem) Vol. 71 Issue 19 Pg. 7146-54 (Sep 15 2006) ISSN: 0022-3263 [Print] United States
PMID16958507 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Disaccharides
  • Galectin 3
  • Ligands
  • galactosyl-1,3-N-acetylglucosamine
  • Acetylglucosamine
Topics
  • Acetylglucosamine (analogs & derivatives, chemical synthesis, chemistry)
  • Chromatography, Affinity
  • Disaccharides (chemical synthesis, chemistry)
  • Galectin 3 (antagonists & inhibitors)
  • Ligands
  • Mass Spectrometry
  • Molecular Structure
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: